Postnatal weight loss and neurodevelopmental outcomes at age 3 years in extremely preterm infants: a cohort study

被引:0
|
作者
Tamai, Kei [1 ]
Matsumoto, Naomi [2 ]
Yorifuji, Takashi [2 ]
Takeuchi, Akihito [1 ]
Nakamura, Makoto [1 ]
Kageyama, Misao [1 ]
机构
[1] NHO Okayama Med Ctr, Div Neonatol, 1711-1 Tamasu,Kita Ku, Okayama 7011192, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Okayama, Japan
关键词
Weight loss; Neurodevelopment; Extremely preterm; Mortality; Developmental impairment; BRONCHOPULMONARY DYSPLASIA; CARE PRACTICES; MORTALITY; MORBIDITY; RISK;
D O I
10.1186/s12887-024-05090-6
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background Previous research has suggested a correlation between postnatal maximum weight loss (MWL) and both neonatal mortality and morbidities in extremely preterm infants. However, the relationship between MWL and neurodevelopmental outcomes remains underexplored. Methods In a single-center, retrospective cohort study at Okayama Medical Center, we evaluated data from extremely preterm infants admitted to the neonatal intensive care unit from 2010 to 2020. Infants who died within the first 10 days of life were excluded. MWL in the first 10 days was the main exposure, categorized into three groups: >15%, 5-15%, and < 5%. The primary outcome evaluated was the occurrence of death or neurodevelopmental impairment (NDI) at age 3 years, defined as developmental impairments (developmental quotient [DQ] < 85), cerebral palsy, hearing impairments, or visual impairments. Data analysis involved robust Poisson regression, adjusted for perinatal confounders, with a restricted cubic spline function to examine the dose-response relationship. We also conducted a sensitivity analysis using a DQ of < 70 to define developmental impairment. Results Among 135 infants assessed for neurodevelopmental outcomes, 40 were in the > 15% MWL group, 71 in the 5-15% group, and 24 in the < 5% group. Median gestational ages and birth weights were 25.9 weeks and 821 g for > 15% MWL; 26.1 weeks and 818 g for 5-15% MWL; and 26.0 weeks and 734 g for < 5% MWL. Compared with the 5-15% MWL group, the < 5% group exhibited a higher risk of death or NDI at age 3 years (62.8% vs. 80.8%, risk ratio [RR] 1.36, 95% confidence interval [CI] 1.04-1.79) and NDI alone (59.2% vs. 79.2%, RR 1.43, 95% CI 1.06-1.94). Furthermore, higher risks of developmental impairment were also noted in the > 15% (RR 1.32, 95% CI 1.00-1.75) and < 5% (RR 1.46, 95% CI 1.08-1.98) groups. These associations were confirmed by spline analyses. In contrast, the associations between MWL and neurodevelopmental outcomes using a DQ of < 70 were not apparent. Conclusions MWL within the first 10 days of life may be associated with increased risks of NDI and developmental impairments by age 3 years in extremely preterm infants.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Respiratory Severity Score and Neurodevelopmental Outcomes at Age 3 Years in Extremely Preterm Infants
    Tamai, Kei
    Takeuchi, Akihito
    Nakamura, Makoto
    Matsumoto, Naomi
    Yorifuji, Takashi
    Kageyama, Misao
    AMERICAN JOURNAL OF PERINATOLOGY, 2024, 41 (13) : 1848 - 1857
  • [2] Neurodevelopmental Changes and Postnatal Growth in the First 3 Years of Extremely Preterm Infants
    Matsunaga, Yuka
    Inoue, Hirosuke
    Miyauchi, Yuta
    Watabe, Takahide
    Yasuoka, Kazuaki
    Sawano, Toru
    Ochiai, Masayuki
    Sakai, Yasunari
    Ohga, Shouichi
    NEONATOLOGY, 2024,
  • [3] Apgar Score and Neurodevelopmental Outcomes at Age 5 Years in Infants Born Extremely Preterm
    Ehrhardt, Harald
    Aubert, Adrien M.
    Aden, Ulrika
    Draper, Elizabeth S.
    Gudmundsdottir, Anna
    Varendi, Heili
    Weber, Tom
    Zemlin, Michael
    Maier, Rolf F.
    Zeitlin, Jennifer
    JAMA NETWORK OPEN, 2023, 6 (09) : E2332413
  • [4] Postnatal betamethasone treatment in extremely preterm infants and risk of neurodevelopmental impairment: a cohort study
    Lofberg, Linn
    Serenius, Fredrik
    Hellstrom-Westas, Lena
    Olhager, Elisabeth
    Ley, David
    Farooqi, Aijaz
    Stephansson, Olof
    Abrahamsson, Thomas
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2024,
  • [5] Postnatal corticosteroids and neurodevelopmental outcomes in extremely low birthweight or extremely preterm infants: 15-year experience in Victoria, Australia
    Cheong, Jeanie Ling
    Anderson, Peter
    Roberts, Gehan
    Duff, Julianne
    Doyle, Lex W.
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2013, 98 (01): : F32 - F36
  • [6] Neurodevelopmental Outcomes of Extremely Preterm Infants
    Vohr, Betty R.
    CLINICS IN PERINATOLOGY, 2014, 41 (01) : 241 - +
  • [7] Small for Gestational Age Affects Outcomes on Singletons and Inborn Births in Extremely Preterm Infants: A Japanese Cohort Study
    Suenaga, Hideyo
    Nakanishi, Hidehiko
    Uchiyama, Atsushi
    Kusuda, Satoshi
    AMERICAN JOURNAL OF PERINATOLOGY, 2024, 41 : e780 - e787
  • [8] Neurodevelopmental outcomes of extremely preterm infants with bronchopulmonary dysplasia (BPD) - A retrospective cohort study
    Nguyen, Khoa L.
    Fitzgerald, Dominic A.
    Webb, Annabel
    Bajuk, Barbara
    Popat, Himanshu
    PAEDIATRIC RESPIRATORY REVIEWS, 2024, 50 : 23 - 30
  • [9] Trends in sex differences in neurodevelopmental outcomes among extremely preterm infants
    Boghossian, Nansi S.
    Mack, Nicole A.
    Bell, Edward F.
    Tan, Sylvia
    Stoll, Barbara J.
    Rysavy, Matthew A.
    Ambalavanan, Namasivayam
    Tyson, Jon E.
    Das, Abhik
    Hintz, Susan R.
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2024,
  • [10] Early feeding behaviours of extremely preterm infants predict neurodevelopmental outcomes
    Rinat, Shie
    Mackay, Margot
    Synnes, Anne
    Holsti, Liisa
    Zwicker, Jill G.
    EARLY HUMAN DEVELOPMENT, 2022, 173